The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Talk2 you must be putting tidy money through and hitting tops and bottoms there, as always don't have L2 so I don't do it.
Excellent day trading so far , rock n roll !!
Testing of people with no symptoms is being banned in some countries because the testing centres are overloaded with work. (and reagents running out)
At the same time, all governments want more testing, in general.
Some say (a professor I heard on TV) that next year if you want to go to a restaurant you'll first drop in at a drive-in style, fast-test village (on the city outskirts). Wait 15 min for a result, collect a certificate, or easier a scan code on your phone. Then proceeed covid-free (like a 1-day pass), into town, to your cafe or restaurant, hassle-free. and the hospitality goes back to normal seating. That could be the (non-spontaneous) future...
I feel this will be float around £9.50 - £9.90 for the next few days pre any RNS update. I think a 'quick' spike may happen but over the past 2/3 weeks this has generally been +10-15% max on a intraday so not sure it will go nuts.
Delighted of course if it does, but I think that presents wider issues on day trading, deramping, MM games on holdings, the whole 'chat' over stop losses and a potential repeat of last Monday.
This will grow for me but I am not as gungho as others expecting it to be an endless daily gravy train.
Market doesn't work like that.
now France 10,30 EURO , nice buying pressure with a move more back up so quickly
looking better , France sp moving back up more
France sp now back up to 10.18 ,,is more of a move back up coming again
France sp now back up to 10.12 ,,is more of a move back up coming again
France ,share price ,now back up to 10,12 Euro ,is a move back up coming again
This doesn’t need an RNS to keep going up. All the technicals are pointing to £13-15 which it can do without any further news.
You can’t sit watching 10p moves in either direction any more, they are only 1 percent now.
We are not living in rational times at present and may not be for some considerable time.
Look at the wider market and many companies in other sectors are in for a further hard fall. This however is a multi billion dollar industry and I don't think normal rules apply to investing in Bio/Pharma at the moment.
MattRempit , Thanks , with ncyt rns now being released at any time of day ,
as seen with last weeks Acquisition rns at 11,30 am ,
hoping they keep releasing mid morning rns ,or 10,00 AM rns , with ncyt seeing so many £million coming in weekly from Global sales ,another Acquisition rns will not surprise .
As we move towards 2021 I reckon the sp will be moved less by new orders and more by the actual pandemic. The more certain that the pandemic is here to stay for the foreseeable future the more the P/e ratio will rise...
You think a large order is going to add £350m to the mcap? Will need to be in the range of half a bil imo for that!
Care home order + large french order could take us to that £13.50 forecast.
Nice summary Sharehunter.
One large order from France will see this jump 50% imho.
another strong day coming up ,
so much news due
with ncyt selling to 130 countries globally
sales of £ millions of products tests globally
the large product / test range ncyt sell
so much news due
care home news due ,
sooner the better ,for the care homes .
winterplex news ,
how much needed to help when hospitals so busy with Flue at this time of year
as well as pcr ,the antigen test
now that ncyt now manufacturing Q16 and Q 32
After last week s Acquisition will ncyt be able to manufacture more machines to fill more or larger orders
part of rns 15 th October
The acquisition of IT-IS reinforces Novacyt's strategy, as announced on 17 September 2020, by strengthening the Company's IP portfolio to enhance and secure future value, as well as further expanding its core capabilities, whilst maintaining attractive margins. It also means the Company is well placed to expand its near-patient product offering through the existing IT-IS instruments and also through new product developments
Well the theoretical open on EuroNext is EUR 10.70 = £9.80 ish, so it sounds like we're due a nice rise at the open, and obviously we're very close to £10+ now
My target price is £40+ so I have no intention of selling any time soon though.
Would just be nice to see this in double digits like it should be!
Then work towards £11